Inhalation Assistance for Lung disease Enhancement 2 (INHALE2)

Purpose and goal

The aim of the project is to improve the inhalation technique for patients with asthma and COPD. The goal is to develop an innovative, quality-secured and easy-to-use product for patients with pulmonary diseases to train inhalation technique in pharmacies and clinics. This will be the first-on-the–market objective measure on inhalation technique.

Expected effects and result

9% of the population has asthma, and 10% of adults have COPD. However, 70% of patients use inhalers incorrectly. Our process will be reproducible, time-efficient, and patient-friendly and improve clinical outcomes. It will lead to significant societal benefits, enhancing medication effectiveness, improving disease control and reducing medication costs. It will lower health complications, hospitalizations, and healthcare costs, ultimately improving general well-being.

Planned approach and implementation

MediTuner will be responisble for product development, following a EU MDR certified quality management system. The Molo Clinic is responsible for user testing and clinical expertise. It has high patient presence and a broad range of clinicians valuable for the project. An expert group will further be formed to evaluate the product during development. The project has been broken down into eight work packages with clear tasks, milestones, outcomes and a pre-determined budget.